<code id='1A11856592'></code><style id='1A11856592'></style>
    • <acronym id='1A11856592'></acronym>
      <center id='1A11856592'><center id='1A11856592'><tfoot id='1A11856592'></tfoot></center><abbr id='1A11856592'><dir id='1A11856592'><tfoot id='1A11856592'></tfoot><noframes id='1A11856592'>

    • <optgroup id='1A11856592'><strike id='1A11856592'><sup id='1A11856592'></sup></strike><code id='1A11856592'></code></optgroup>
        1. <b id='1A11856592'><label id='1A11856592'><select id='1A11856592'><dt id='1A11856592'><span id='1A11856592'></span></dt></select></label></b><u id='1A11856592'></u>
          <i id='1A11856592'><strike id='1A11856592'><tt id='1A11856592'><pre id='1A11856592'></pre></tt></strike></i>

          Home / Wikipedia / knowledge

          knowledge


          knowledge

          author:fashion    Page View:4747
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In